Editorial: Imaging assessment of response to immunotherapy.

Competing Interests: MO reports personal fees from Radiomics, outside the submitted work. SW have shares in the company Radiomics. ARF discloses speakers’ bureau from Astra Zeneca, MSD, Roche, Ipsen; advisory role for Astra Zeneca, Roche; research funding from Astra Zeneca. Participation (no financial interest) to sponsored research from Astra Zeneca, Roche, MSD, all outside of the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.